| 0 (0%) | 11-10 12:07 | |||||||||||||
|
|
| Short term | |
|||
| Mid term | ||||
| Targets | 6-month : | 16.31 |
1-year : | 19.05 |
| Resists | First : | 13.97 |
Second : | 16.31 |
| Pivot price | 11.07 |
|||
| Supports | First : | 11.07 |
Second : | 9.27 |
| MAs | MA(5) : | 11.44 |
MA(20) : | 10.97 |
| MA(100) : | 9.2 |
MA(250) : | 8.68 |
|
| MACD | MACD : | 0.3 |
Signal : | 0.2 |
| %K %D | K(14,3) : | 55.1 |
D(3) : | 44 |
| RSI | RSI(14): 54.1 |
|||
| 52-week | High : | 18.21 | Low : | 5.36 |
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.[ DNA ] has closed below upper band by 30.7%. Bollinger Bands are 29.7% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 13.14 - 13.19 | 13.19 - 13.23 |
| Low: | 10.95 - 11 | 11 - 11.04 |
| Close: | 12.28 - 12.37 | 12.37 - 12.45 |
Tue, 10 Nov 2026
Researchers identify DNA marker that could predict treatment response in myelodysplastic syndromes - Medical Xpress
Tue, 10 Nov 2026
Quiet serial killers may hide in plain sight as DNA unmasks dead 1970s Pennsylvania strangler, expert says - Fox News
Tue, 10 Nov 2026
DNA enhancer switch drives androgen receptor breast cancer suppression - Drug Target Review
Mon, 09 Nov 2026
1992 AZ cold case victim identified through DNA tests - KTAR News 92.3 FM
Mon, 09 Nov 2026
Judge limits DNA evidence ahead of Bozeman homicide trial - KBZK News
Mon, 09 Nov 2026
Ancient DNA From 700 Skeletons Just Rewrote the Origin Story of the Languages We Speak Today - Yahoo
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
|
|
|
Sector:
|
|
|
Industry:
|
|
| Shares Out | 55 (M) |
| Shares Float | 48 (M) |
| Held by Insiders | 4.5 (%) |
| Held by Institutions | 74.6 (%) |
| Shares Short | 8,290 (K) |
| Shares Short P.Month | 7,170 (K) |
| EPS | -4.24 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 6.13 |
| Profit Margin | -192 % |
| Operating Margin | -157.5 % |
| Return on Assets (ttm) | -15.8 % |
| Return on Equity (ttm) | -58.3 % |
| Qtrly Rev. Growth | -28.7 % |
| Gross Profit (p.s.) | 1.64 |
| Sales Per Share | 2.36 |
| EBITDA (p.s.) | -4.25 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -167 (M) |
| Levered Free Cash Flow | -91 (M) |
| PE Ratio | -2.82 |
| PEG Ratio | 0 |
| Price to Book value | 1.94 |
| Price to Sales | 5.05 |
| Price to Cash Flow | -3.96 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |